Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dopamine and Yohimbine

supplement:

Yohimbine

Research Papers that Mention the Interaction

In analogy, yohimbine enhances FCX levels of DA and NAD, yet suppresses those of 5‐HT, the latter effect being antagonized by WAY100,635.
While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5‐HT.
Synapse  •  2000  |  View Paper
Similarly to neuroleptic agents, yohimbine reduced striatal acetylcholine concentrations and counteracted the dopamine (10(-5) M)-induced inhibition of the potassium-evoked release of [3H]acetylcholine from slices of caudate nucleus.
The Journal of pharmacology and experimental therapeutics  •  1980  |  View Paper
RESULTS Both oral domperidone and yo imbine in duced a significant increase in both plasma norepinephrine and plasma dop amine.
Journal of hypertension  •  1992  |  View Paper
Yohimbine inhibits tryptophan,3may stimulate serotonin receptors,4and, above …, may induce a preferential destruction of newly synthesized dopamine and a depletion of stored noradrenaline.5Thus, when using such a complex pharmacologic tool as yohimbine, it is not possible to draw any direct clinical inference by ascribing it to only
Archives of general psychiatry  •  1988  |  View Paper
Dopamine (DA) … by yohimbine in the WT but unaffected in the KO mice, suggesting that NPY-Y2 receptor exerts a direct control over both the tonic and … and that, although the anxiety-like behavior of these NPY-Y2 KO mice is unaltered, there are clear modifications of DA dynamics.
Neuroscience  •  2011  |  View Paper
Even after blocking the alpha(2)-adrenoceptor with yohimbine , the inhibitory effect of DA still remained, indicating separate action of DA from AD or NA.
Journal of experimental zoology. Part A, Comparative experimental biology  •  2006  |  View Paper
Interestingly, a behaviorally ineffective dose of yohimbine markedly reduced the inhibitory effects of DA when injected 15min before.
Behavioural Brain Research  •  2005  |  View Paper
The turnover of dopamine and noradrenaline in the mouse brain, as assessed by the disappearance of catecholamines following treatment with the tyrosine hydroxylase inhibitorα-methyltyrosine, was accelerated by yohimbine with a peak effect after 10 mg/kg intraperitoneally.
Yohimbine did not stimulate motor activity following 10 mg/kg and it retarded the turnover of dopamine following 30 mg/kg.
completely antagonized the stimulatory effect of yohimbine on motor activity and on dopamine turnover but it somewhat potentiated the stimulatory effect on the turnover of noradrenaline.
Journal of Neural Transmission  •  2005  |  View Paper
Both sulpiride and domperidone, but not yohimbine , also antagonized the inhibitory effect of dopamine on the indomethacin-induced intestinal hypermotility.
Medical science monitor : international medical journal of experimental and clinical research  •  2003  |  View Paper
Yohimbine (alpha2-adrenoceptor antagonist, 0.3 micromol l-1) significantly (P<0.05) attenuated the inhibitory effects of dopamine and caused an upward shift in the concentration-response curves in the vas deferens and the urinary bladder.
Pharmacological research  •  1999  |  View Paper
Show More